Use of NMR and fluorescence spectroscopy as well as theoretical conformational analysis in conformation-activity studies on cyclic enkephalin analogues

Current Topics in Medicinal Chemistry

Volumn 4, Issue 1, 2004, Pages 123-133

  Malicka, Joanna ^a   Czaplewski, Cezary ^a   Groth, Malgorzata ^a   Wiczk, Wieslaw ^a   Oldziej, Stanislaw ^a   Lankiewicz, Leszek ^a   Ciarkowski, Jerzy ^a   Liwo, Adam ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN DERIVATIVE; GLYCINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; LEUCINE; METHIONINE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; PENICILLAMINE; PHENYLALANINE; TYROSINE; CYCLOPEPTIDE; ENKEPHALIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CYCLIZATION; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; FLUORESCENCE SPECTROSCOPY; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CONFORMATION; RETROSPECTIVE STUDY; REVIEW; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; METHODOLOGY; SPECTROFLUOROMETRY;

ENKEPHALINS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2142709476     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043451591     Document Type: Review

References (112)

1. Hruby, V. J.; Gehring, C. A. Recent developments in the design of receptor specific opioid peptides. Med. Res. Rev. 1989, 9, 343-401.
2. Hruby, V. J.; Agnes, R. S. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors. Biopolymers 1999, 51, 391-410.
3. Kosterlitz, H. W.; Watt, A. J. Kinetic parameters of narcotic agonists and antagonists with particular reference to n-allylnoroxymorphone (naloxone). Br. J. Pharmacol. Chemother. 1968, 33, 266-276.
4. Hughes, J.; Kosterlitz, H. W.; Leslie, F. M. Effect of morphine on adrenergic transmission in mouse vas-deferens assessment of agonist and antagonist potencies of narcotic analgesics. Br. J. Pharmacol. 1975, 53, 371-381.
5. Morgan, B. A.; Smith, C. F. C.; Waterfield, A. A.; Hughes, J.; Kosterlitz, H. W. Structure-activity-relationships of methionine-enkephalin. J. Pharm. Pharmacol. 1976, 28, 660-661.
6. 5]-enkephalin - comparison of fluorescence parameters at different pH. Biochem. Biophys. Res. Commun. 1977, 79, 493-498.
7. Maryanoff, B. E.; Zelesko, M. J. Stereochemical considerations in structural comparison of enkephalins and endorphins with exogenous opiate agents. J. Pharm. Sci. 1978, 67, 590-591.
8. 2 -Metenkephalinamide - potent, long-lasting synthetic pentapeptide analgesic. Science 1976, 194, 330-332.
9. Shaw, J. S.; Turnbull, M. J. In vitro profile of some opioid pentapeptide analogs. Eur. J. Pharmacol. 1978, 49, 313-317.
10. Horn, A. S.; Rodgers, J. R. Structural and conformational relationships between enkephalins and opiates. Nature 1976, 260, 795-797.
11. Horn, A. S.; Rodgers, J. R. Enkephalins and opiates - structure-activity relations. J. Pharm. Pharmacol. 1977, 29, 257-265.
12. Dutta, A. S.; Gormley, J. J.; Hayward, C. F.; Morley, J. S.; Shaw, J. S.; Turnbull, M. T. Encephalin-like peptides - structure-activity relationships. Acta Pharm. Suec., Suppl. 1977, 14, 14-15.
13. Casiano, F. M.; Cumiskey, W. R.; Gordon, T. D.; Hansen, P. E.; McKay, F. C.; Morgan, B. A.; Pierson, A. K.; Rosi, D.; Singh, J.; Terminello, L.; Ward, S. J.; Wesco, D. M. In Hruby, V. J.; Rich, D. H., editors, Peptides: Structure and Functions. Proc. 8th Amer. Pept. Symp., page 311. Pierce Chemical Co., Rockford IL, 1983.
14. Lord, J. A. H.; Waterfield, A. A.; Hughes, J.; Kosterlitz, H. W. Endogenous opioid peptides-multiple agonists and receptors. Nature 1977, 267, 495-499.
15. Gacel, G.; Zajac, J. M.; Dealy-Goyet, P.; Daugé, V.; Roques, B. P. Investigation of the structural parameters involved in the μ and δ-opioid receptor discrimination of linear enkephalin-related peptides. J. Med. Chem. 1988, 31, 374-383.
16. Schiller, P. W.; Yam, Ch. T.; Prosmanne, J. Synthesis, opiate receptor affinity, and conformational parameters of [4-tryptophan]enkephalin analogs. J. Med. Chem. 1978, 21, 1110-1116.
17. Schiller, P. W.; Nguyen, T. M.-D.; DiMaio, J.; Lemieux, C. Comparison of μ-receptor, δ-receptor and κ-receptor binding-sites through pharmacologic evaluation of para-nitrophenylalanine analogs of opioid-peptides. Life Sci. 1983, 33, 319-322.
18. 5) enkephalinamide - 2 potent agonists of opiate and enkephalin receptors. FEBS Lett. 1980, 110, 88-90.
19. Morgan, B. A.; Bower, J. D.; Guest, K. P.; Handa, B. K.; Metcalf, G.; Smith, C. F. C. In Goodman, M.; Meienhofer, J., editors, Peptides, Proc. 5th Amer. Pept. Symp., page 111. Wiley, New York, 1977.
20. Handa, B. K.; Lane, A. C.; Lord, J. A. H.; Morgan, B. A.; Rance, M. J.; Smith, C. F. C. Analogs of β-lph61-64 possessing selective agonist activity at μ-opiate receptors. Eur. J. Pharmacol. 1981, 70, 531-540.
21. Schiller, P. W.; DiMaio, J. Opiate receptor subclasses differ in their conformational requirements. Nature 1982, 297, 74-76.
22. DiMaio, J.; Nguyen, T.M.-D.; Lemieux, C.; Schiller, P. W. Synthesis and pharmacological characterization invitro of cyclic enkephalin analogs - effect of conformational constraints on opiate receptor selectivity. J. Med. Chem. 1982, 25, 1432-1438.
23. 1H-NMR and computer simulations. Biopolymers 1987, 26, 1573-1586.
24. Mierke, D. F.; Said-Nejad, O. E.; Schiller, P. W.; Goodman, M. Enkephalin analogues containing β-naphtylatanine at the fourth position. Biopolymers 1990, 29, 179-196.
25. Yamazaki, T.; Said-Nejad, O. E.; Schiller, P. W.; Goodman, M. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphtylaianine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity. Biopolymers 1991, 31, 877-898.
26. Said-Nejad, O. E.; Felder, E. R.; Mierke, D. F.; Yamazaki, T.; Schiller, P. W.; Goodmand, M. 14-membered cyclic opioids; related to dermorphin and their partially retro-inverso modified analogs. 1. Synthesis and biological-activity. Int. J. Pept. Prot. Res. 1992, 39, 145-160.
27. Schiller, P. W.; DiMaio, J.; Nguyen, T. M.-D. In Ovchinnikov, Y. A., editor, Proc. 16th FEBS Meeting, page 457. VUN Science Press, Utrecht, The Netherlands, 1985.
28. Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Gee, K.; Yamamura, H. I.; Galligan, J. J.; Burks, T. F. Bis-penicillamine enkephalins possess highly improved specificity toward δ-opioid receptors. Proc. Natl. Acad. Sci. USA 1983, 80, 5871-5874.
29. Pawlak, D.; Chung, N. N.; Schiller, P. W.; Izdebski, J. Synthesis of a novel side-chain to side-chain cyclized enkephalin analogue containing a carbonyl bridge. J. Pept. Sci. 1997, 3, 277-281.
30. Pawlak, D.; Oleszczuk, M.; Wójcik, J.; Pachulska, M.; Chung, N. N.; Schiller, P. W.; Izdebski, J. Highly potent side-chain to side-chain cyclized enkephalin analogues containing a carbonly bridge: synthesis, biology, and conformation. J. Pept. Sci. 2001, 7, 128-140.
31. Wüthrich, K. NMR of Proteins and Nucleic Acids. Wiley, New York, 1986.
32. Wagner, G. NMR investigation of protein structure. Progress in NMR spectroscopy 1990, 23, 101-139.
33. Yang, J.-X.; Havel, T. F. SESAME: A least-squares approach to the evaluation of protein structures computed from NMR data. J. Biomol. NMR 1993, 3, 355-360.
34. Torda, A. E.; van Gunsteren, W. F. Molecular modeling using nuclear magnetic resonance data. In Lipkowitz, K. B.; Boyd, D. B., editors, Reviews of Computational Chemistry, volume 3, pages 143-172. VCH Publishers, 1992.
35. Brüschweiler, R.; Blackledge, M.; Ernst, R.R. Multi-conformational peptide dynamics derived from NMR data: A new search algorithm and its application to antamanide. J. Biomol. NMR 1991, 1, 3-11.
36. Blackledge, M. J.; Brüschweilcr, R.; Greisinger, C.; Schmidt, J. M.; Xu, P.; Ernst, R. R. Conformational backbone dynamics of the cyclic decapeptide antamanide. Application of a new multiconformational search algorithm based on NMR data. Biochemistry 1993, 32, 10960-10974.
37. Groth, M.; Malicka, J.; Rodziewicz-Motowidlo, S.; Czaplewski, C.; Klaudel, L.; Wiczk, W.; Liwo, A. Determination of conformational equilibrium of peptides in solution by NMR spectroscopy and theoretical conformational analysis: application to the calibration of mean-field solvation models. Biopolymers 2001, 60, 79-95.
38. 5]enkephalin. J. Biomol. NMR 1999, 4, 315-330.
39. Malicka, J.; Groth, M.; Czaplewski, C.; Liwo, A.; Wiczk, W.; Lankiewicz, L. Computer modeling of the solution conformation of cyclic enkephalins. Lett. Pept. Sci. 1998, 5, 445-447.
40. Malicka, J.; Groth, M.; Czaplewski, C.; Karolczak, J.; Liwo, A.; Wiczk, W. Influence of solvent and configuration of residues at position 2 and 3 on distance and mobility of pharmacophore group at position 1 and 4 in cyclic enkephalin analogues. Biopolymers 2001, 59, 180-190.
41. Malicka, J.; Groth, M.; Karolczak, J.; Czaplewski, C.; Liwo, A.; Wiczk, W. Influence of solvents and leucine configuration at position 5 on tryptophan fluorescence in cyclic enkephalin analogues. Biopolymers 2001, 58, 447-457.
42. Malicka, J.; Groth, M.; Czaplewski, C.; Wiczk, W.; Liwo, A. Conformational studies of cyclic enkephalin analogues with L- or D-proline in position 3. Biopolymers 2002, 63, 217-231.
43. Post, C. B.; Meadows, R. P.; Gorenstein, D. G. On the evaluation of interproton distances for 3-dimensional structure determination by NMR using a relaxation rate matrix analysis. J. Am. Chem. Soc. 1990, 112, 6796-6803.
44. Meadows, R. P.; Post, C. B.; Luxon, B. A.; Gorenstein, G. D. MORASS 2. 1. Purdue University, W. Lafayette, 1994.
45. Bystrov, V. F. Spin-spin coupling and the conformational states of peptide systems.Progress in NMR Spectroscopy 1976, 10, 41-81.
46. Ripoll, D. R.; Liwo, A.; Czaplewski, C. The ECEPP package for conformational analysis of polypeptides. TASK Quart. 2000, 3, 313-323.
47. http://www.tc. cornell.edu/research/cbsu/ software/analyze; http://www.task.gda.pl/software/analyze.
48. Weiner, S. J.; Kolman, P. A; Nguyen, D. T.; Case, D. A. An all-atom force field for simulations of proteins and nucleic acids. J. Comput. Chem. 1986, 7, 230-252.
49. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 1983, 4, 187-217.
50. Dauber-Osguthorpe, P.; Roberts, V. A.; Osguthorpe, D. J.; Wolff J.; Genest, M.; Hagler, A. T. Structure and energetics of ligand binding to proteins: E. coli dihydrofolate reductase- trimethoprim, a drug-receptor system. Proteins: Struct. Funct. Genet. 1988, 4, 31-47.
51. Némethy, G.; Gibson, K. D.; Palmer, K. A.; Yoon, C. N.; Paterlini, G.; Zagari, A.; Rumsey, S.; Scheraga, H. A. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm with application to proline-containing peptides. J. Phys. Chem. 1992, 96, 6472-6484.
52. Hermans, J.; Berendsen, H. J. C.; van Gunsteren, W. F.; Postma, J. P. M. A consistent empirical potential for water-protein interactions. Biopolymers 1984, 23, 1513-1518.
53. Brünger, A. T.; Karplus, M. Molecular dynamics simulations with experimental restraints. Acc. Chem. Res. 1991, 24, 54-61.
54. Vila, J.; Williams, R. L.; Vásquez, M.; Scheraga, H. A. Empirical solvation models can be used to differentiate native from near-native conformations of bovine pancreatic trypsin inhibitor. Proteins: Struct Funct. Genet. 1991, 10, 199-218.
55. Bashford, D.; Case, D. A. Generalized Born models of macromolecular solvation effects. Annu. Rev. Phys. Chem. 2000, 51, 129-152.
56. Vasquez, M.; Némethy, G.; Scheraga, H. A. Conformational energy calculations on polypeptides and proteins. Chem. Rev. 1994, 94, 2183-2239.
57. Ripoll, D. R.; Scheraga, H. A. The multiple-minima problem in the conformational analysis of potypeptides. III. An electrostatically driven Monte Carlo method; tests on enkephalin. J. Protein Chem. 1989, 8, 263-287.
58. Ripoll, D. R.; Liwo, A.; Scheraga, H. A. New developments of the electrostatically driven Monte Carlo method - Test on the membrane bound portion of melittin. Biopolymers 1998, 46, 117-126.
59. http://www.tc.cornell.edu/research/cbsu/software/eceppak; http://www.task.gda.pl/software/eceppak.
60. Lee, J.; Scheraga, H.A.; Rackovsky, S. New optimization method for conformational energy calculations on polypeptides: Conformational space annealing. J. Comput. Chem. 1997, 18, 1222-1232.
61. Haas, E.; Wilchek, M.; Katchalski-Katzir, E.; Steinberg, I. Z. Distribution of end-to-end distances of oligopeptides in solution as estimated by energy-transfer. Proc. Natl. Acad. Sci. USA 1975, 72, 1807-1811.
62. Haas, E.; Katchalski-Katzir, E.; Steinberg, I. Z. Brownian-motion of ends of oligopeptide chains in solution as estimated by energy-transfer between chain ends. Biopolymers 1978, 17, 11-31.
63. Bradbury, A. F.; Smyth, D. G.; Snell, C. R. Biosynthetic origin and receptor conformation of methionine enkephalin. Nature 1976, 260, 165-166.
64. Hudson, D.; Sharpe, R.; Szelke, M. Methionine enkephalin and isosteric analogs. 2. Receptor conformation of methionine enkephalin. Int. J. Pept. Protein Res. 1980, 15, 122-129.
65. 5]enkephalin from X-ray-diffraction - features important for recognition at opiate receptor. Science 1978, 199, 1214-1216.
66. Blundell, T. L.; Hearn, L.; Tickle, I. J.; Palmer, R. A.; Morgan, B. A.; Smith, G. D.; Griffin, J. F. Crystal-strUcture of [Leu-5]enkephalin. Science 1979, 205, 220-220.
67. Ishida, T.; Kenmotsu, M.; Mino, Y.; jnoue, M.; Fujiwara, T.; Tomita, K.; Kimura, T.; Sakakibara, S. X-ray-diffraction studies of enkephalins - crystal-structure of [(4′-bromo)phe4,leu5]enkephalin. Biochem. J. 1984, 218, 677-689.
68. 5]-enkephalin in the crystal and in solution. Int. J. Pept. Protein Res. 1980, 16, 173-182.
69. Camerman, A.; Mastropaolo, D.; Karte, L; Karle, J.; Camerman, N. Crystal-structure of leucine-enkephalin. Nature (London) 1983, 306, 447-450.
70. Garbay-Jauregui berry, C.; Marion, D.; Fellion, E.; Roques, B. P. Refinement of conformational preferences of Leu enkephalin and Tyr-Gly-Gly-Phe by N-15 NMR - chemical-shifts and vicinal coupling-constants. Int. J. Pept. Protein Res. 1982, 20, 443-450.
71. 5-enkephalin. Biochemistry 1979, 18, 1661-1671.
72. Fischman, A. J.; Riemen, M. W.; Cowburn, D. Averaging of phi-2 and phi-3 in [5-leucyl]-enkephalin - NMR-study of 2 isotopic isomers. FEBS Lett. 1979, 94, 236-240.
73. Higashijima, T.; Kobayashi, J.; Nagai, U.; Miyazawa, T. NMR-study on Met-enkephalin and Met-enkephalinamide - molecular association and conformation. Eur. J. Biochem. 1979, 97, 43-57.
74. Khaled, M. A.; Urry, D. W.; Bradley, R. J. pH and solvent titrations of enkephalins by C-13 nuclear magnetic-resonance spectroscopy- complete assignments of resonances. J. Chem, Soc. Perk. Transk. II 1979, 1693-1699.
75. Spirtes, M. A.; Schwartz, R. W.; Mattice, W. L.; Coy, D. H. Circular-dichroism and absorption study ofstructure of methionine-enkephalin in solution. Biochem. Biophys. Res. Commun. 1978, 81, 602-609.
76. Demonte, J.-P.; Guillard, R.; Englert, A. Theoretical conformational-analysis of enkephalin analogs related to fluorescence and NMR measurements in aqueous- solution. Int. J. Pept. Prot. Res. 1981, 18, 478-486.
77. Momany, F. A.; McGuire, R. F.; Burgess, A. W.; Scheraga, H. A. Energy parameters in polypeptides. VII. Geometric parameters, partial atomic charges, non-bonded interactions, hydrogen bond interactions and intrinsic torsional potential for the naturally occurring amino-acids. J. Phys. Chem. 1975, 79, 2361-2381.
78. Némethy, G.; Pottle, M. S.; Scheraga, H. A. Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acids. J. Phys. Chem. 1983, 87, 1993-1887.
79. Isogai, Y.; Némethy, G.; Scheraga, H. A. Enkephalin: conformational analysis by means of empirical energy calculations. Proc. Natl. Acad. Sci., U.S.A. 1977, 74, 414-418.
80. Garbay-Jaureguiberry, C.; Roques, B. P.; Oberlin, R.; Anteunis, M.; Lala, A. K. Preferential conformation of endogenous opiate-like pentapeptide Met-enkephalin in DMSO-d6 solution determined by high-field H-1 NMR. Biochem. Biophys. Res. Commun. 1976, 71, 558-565.
81. DeCoen, J. L.; Humblet, C.; Koch, M. H. J. Theoretical conformational-analysis of Met-enkephalin. FEBS Lett. 1977, 73, 38-42.
82. Nikiforovich, G. V.; Prakash, O.; Gehrig, C. A.; Hruby, V. J. Conformations of the dermenkephalin backbone in DMSO solution by a new approach to the solution conformation of flexible peptides. J. Am. Chem. Soc. 1993, 115, 3339-3406.
83. Hall, D.; Pavitt, N. Conformation of a cyclic tetrapeptide related to an analog of enkephalin. Biopolymers 1984, 23, 1441-1455.
84. 2bu-Gly-Phe-Leu-). Mol. Pharmacol. 1986, 29, 314-320.
85. 1H NMR and computer simulations. J. Am. Chem. Soc, 1984, 107, 4008-4013.
86. Hall, D.; Pavitt, N. Conformation of cyclic analogs of enkephalin. 3. Effect of varying ring size. Biopolymers 1985, 24, 935-945.
87. Kessler, H.; Hölzemann, G.; Zechel, C. Peptide conformations. 33. Conformational-analysis of cyclic enkephalin analogs of the type Tyr-cyclo-(-N-omega-XXX-Gly-Phe-Leu-). Int. J. Pept. Protein Res. 1985, 25, 267-279.
88. Bolme, P.; Fuxe, K.; Agnati, L. F.; Bradley, R.; Smythies, J. Cardiovascular and respiratory effects of morphine and opioid peptides given intracisternally in α-chloralose anesthetized rats. Acta Pharmacol. Toxicol. 1977, 41, 42-42.
89. Schiller, P. W. Fluorescence study on the conformation of a cyclic enkephalin analog in aqueous-solution. Biochem. Biophys. Res. Commun. 1983, 114, 268-274.
90. Kolp, B.; Andreada, F.; Fabian, W. M. F.; Sterk, H. Combined use of NMR, distance geometry and MD calculations for the conformational analysis of opioid peptides of the type [D(L)-Cys(2), D(L)-Cys(5)] enkephalin. Int. J. Pept. Protein Res. 1996, 48, 443-451.
91. Hruby, V. J.; Li, G.; Haskell-Luevano, C.; Shenderovich, M. Design of peptides, proteins, and peptidomimetics in chi space. Biopolymers 1997, 43, 219-266.
92. Mosberg, H. I.; Schiller, P. W. H-1-NMR investigation of conformational features of cyclic enkephalinamide analogs. Int. J. Pept. Protein Res. 1984, 23, 462-466.
93. Mosberg, H. I. H-1-NMR investigation of conformational features of cyclic, penicillamine-containing enkephalin analogs. Int. J. Pent. Protein Res. 1987, 29, 292-288.
94. 5]enkephalin in aqueous-solution determined by NMR and energy minimization calculations. J. Am. Chem. Soc. 1988, 110, 3351-3359.
95. 5]Enkephalin. J. Am. Chem. Soc. 1990, 112, 822-829.
96. Flippen-Anderson, J. L.; Hruby, V. J.; Collins, N.; George, C.; Cudney, B. X-ray structure of [D-Pen(2),D-Pen(5)]enkephalin, a highly potent, δ-opioid receptor-selective compound - comparisons with proposed solution conformations. J. Am. Chem. Soc. 1994, 116, 7523-7531.
97. Collins, N.; Flippen-Anderson, J. L.; Haaseth, R. C.; Deschamps, J. R.; George, C.; Kövér, K.; Hruby, V. J. Conformational determinants of agonist versus antagonist properties of [D-Pen(2),D-Pen(5)]enkephalin (DPDPE) analogs at opioid receptors. Comparison of x-ray crystallographic structure, solution H-1 NMR data, and molecular dynamic simulations of [L-Ala(3)]DPDPE and [D-Ala(3)]DPDPE. J. Am. Chem. Soc. 1996, 118, 2143-2152.
98. Froimowitz, M.; Hruby, V. J. Con formational-analysis of enkephalin analogs containing a disulfide bond - models for δ -receptor and μ-receptor opioid agonists. Int. J. Pept. Prot. Res. 1989, 34, 88-96.
99. Nikiforovich, G. V.; Balodis, J.; Shenderovich, M. D.; Golbraikh, A. A. Conformational features responsible for binding of cyclic analogs of enkephalin to opioid receptors. Int. J. Pept. Prot. Res. 1990, 36, 67-78.
100. Nikiforovich, G. V.; Hruby, V. J.; Prakash, O. M.; Gehrig, C. A. Topographical requirements for δ-selective opioid-peptides. Biopolymers 1991, 31, 941-955.
101. Qian, X. H.; Kövér, K.; Shenderovich, M. D.; Lou, B.-S.; Misicka, A.; Zalewska, T.; Horváth, R.; Davis, P.; Bilsky, R.; Porreca, F.; Yamamura, H. I.; Hruby, V. J. Newly discovered stereochemical requirements in the side-chain conformation of delta-opioid agonists for recognizing opioid δ-receptors. J. Med. Chem. 1994, 37, 1746-1757.
102. Qian, X. H.; Shenderovich, M. D.; Kövér, K.; Davis, P.; Horváth, R.; Zalewska, T.; Yamamura, H. I.; Porreca, F.; Hruby, V. J. Probing the stereochemical requirements for receptor recognition of δ opioid agonists through topographic modifications in position 1. J. Am. Chem. Soc. 1996, 118, 7280-7290.
103. Shenderovich, M. D.; Liao, S.; Qian, X.; Hruby, V. J. A three-dimensional model of the δ-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands. Biopolymers 2000, 53, 565-580.
104. Malicka, J.; Groth, M.; Czaplewski, C.; Liwo, A.; Wiczk, W. Fluorescence decay time distribution analysis of cyclic enkephalin analogues. Influence of the solvents and configuration of amino acids in position 2 and 3 on changes in conformation. Acta Biochim. Pol. 1999, 46, 615-629.
105. Malicka, J.; Czaplewski, C.; Groth, M.; Kubicki, A.; Arlukowicz, P.; Wiczk, W.; Liwo, A. Studies of inter-pharmacophore distance in cyclic enkephalin analogues by fluorescence spectroscopy and molecular dynamics. In Bajusz, S.; Hudeez, F., editors, Peptides 1998, pages 368-369. Akademiai Kiadó, Budapest, 1999.
106. Ananthanarayanan, V. S.; Zhorov, B. S. A novel receptor activation mechanism revealed by modeling μ-opioid receptor-ligand complexes. FASEB J. 1997, 11, 2909-2809 Suppl. S.
107. Poda, G.; Maigret, B. Computer modeling of δ opioid receptor and interaction with ligands. Lett. Pept. Sci. 1998, 5, 193-197.
108. Lomize, A. L.; Pogozheva, I. D.; Mosberg, H. I. Structural organization of G-protein-coupled receptors. J. Compt.-Aided Molec. Des. 1999, 13, 325-353.
109. Wan, X. H.; Huang, X. Q.; Zhou, D. H.; Jiang, H. L.; Feng, Y. P.; Chen, K. X.; Chi, Z. Q. Molecular modeling of κ opioid receptor-Gi protein recognition. Prot. Pept. Lett. 2000, 7, 403-409.
110. Mosberg, H. I.; Fowler, C. B. Development and validation of opioid ligand-receptor interaction models: The structural basis of μ vs. δ selectivity. J. Pept. Res. 2002, 60, 329-335.
111. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, L; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289, 739-745.
112. Koradi, R.; Billeter, M.; Wathrich, K. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graphics 1996, 15, 51-55.